WallStreetZenWallStreetZen

NASDAQ: SNPX
Synaptogenix Inc Stock

$0.22+0.02 (+10%)
Updated Feb 28, 2024
SNPX Price
$0.22
Fair Value Price
N/A
Market Cap
$4.42M
52 Week Low
$0.14
52 Week High
$1.88
P/E
-0.21x
P/B
0.17x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$560.19k
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.15
Operating Cash Flow
-$7M
Beta
1.17
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

SNPX Overview

Synaptogenix Incorporated is a biopharmaceutical company developing a product platform for the treatment of Alzheimer's based upon a drug candidate called Bryostatin-1. It is also assessing therapeutic applications of Bryostatin-1 for other neurodegenerative and cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-Pick Type C disease. Synaptogenix was incorporated in 2012 and is headquartered in New York, NY.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SNPX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SNPX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SNPX is good value based on its book value relative to its share price (0.17x), compared to the US Biotechnology industry average (6.14x)
P/B vs Industry Valuation
SNPX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SNPX due diligence checks available for Premium users.

Be the first to know about important SNPX news, forecast changes, insider trades & much more!

SNPX News

Valuation

SNPX fair value

Fair Value of SNPX stock based on Discounted Cash Flow (DCF)
Price
$0.22
Fair Value
$4.96
Undervalued by
95.57%
SNPX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

SNPX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.21x
Industry
13.96x
Market
35.52x

SNPX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.17x
Industry
6.14x
SNPX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SNPX's financial health

Profit margin

Revenue
$0.0
Net Income
$763.2k
Profit Margin
0%
SNPX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$32.4M
Liabilities
$3.9M
Debt to equity
0.15
SNPX's short-term assets ($32.34M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SNPX's short-term assets ($32.34M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SNPX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.2M
Investing
$0.0
Financing
$49.0
SNPX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SNPX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
SNPX$4.42M+7.96%-0.21x0.17x
XTLB$4.38M-6.51%-4.02x1.10x
GOVX$4.52M-6.27%-0.19x0.50x
PTIX$4.30M+10.11%-1.06x1.03x
IBIO$4.22M+3.42%-0.08x0.46x

Synaptogenix Stock FAQ

What is Synaptogenix's quote symbol?

(NASDAQ: SNPX) Synaptogenix trades on the NASDAQ under the ticker symbol SNPX. Synaptogenix stock quotes can also be displayed as NASDAQ: SNPX.

If you're new to stock investing, here's how to buy Synaptogenix stock.

What is the 52 week high and low for Synaptogenix (NASDAQ: SNPX)?

(NASDAQ: SNPX) Synaptogenix's 52-week high was $1.88, and its 52-week low was $0.14. It is currently -88.46% from its 52-week high and 53.9% from its 52-week low.

How much is Synaptogenix stock worth today?

(NASDAQ: SNPX) Synaptogenix currently has 20,390,833 outstanding shares. With Synaptogenix stock trading at $0.22 per share, the total value of Synaptogenix stock (market capitalization) is $4.42M.

Synaptogenix stock was originally listed at a price of $4.20 in Dec 9, 2020. If you had invested in Synaptogenix stock at $4.20, your return over the last 3 years would have been -94.83%, for an annualized return of -62.75% (not including any dividends or dividend reinvestments).

How much is Synaptogenix's stock price per share?

(NASDAQ: SNPX) Synaptogenix stock price per share is $0.22 today (as of Feb 28, 2024).

What is Synaptogenix's Market Cap?

(NASDAQ: SNPX) Synaptogenix's market cap is $4.42M, as of Feb 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Synaptogenix's market cap is calculated by multiplying SNPX's current stock price of $0.22 by SNPX's total outstanding shares of 20,390,833.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.